Company Overview
- Website
- antiostherapeutics.com
- Phone
- (215) 696-9659
- Employees
- 3
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$10B
Recent News & Media
Hepatitis D Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Eiger Biopharmaceuticals, Arrowhead Pharmaceuticals, Antios Therapeutics, PharmaEsse
- Jun 25, 2025
- theglobeandmail.com
Hep B biotech Antios closed after FDA hold proved insurmountable
- Sep 22, 2023
- fiercebiotech.com
Antios therapy could be a 'bridge' in hep B treatment, but first: an FDA hold to resolve
- Jun 27, 2022
- fiercebiotech.com
Antios rocked as hepatitis B safety signal sparks clinical hold, termination of collaboration
- May 25, 2022
- fiercebiotech.com
Antios Therapeutics' ATI-2173 Demonstrates Suppression of Hepatitis B Virus in Phase 1b and 2a Studies
- Mar 30, 2022
- firstwordpharma.com
Antios, months after series B, raises a further $75M to fuel pursuit of hepatitis B cure
- Nov 3, 2021
- fiercebiotech.com
Companies Similar to Antios Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Antios Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 59 | Boston, MA | ||
| 10M | 27 | Cambridge, MA | 2010 | |
| 10M | 23 | Waltham, MA | 1999 | |
| 10M | 2 | Boston, MA | ||
| 10M | 46 | Woburn, MA |